-
Over 1.16b Chinese fully vaccinated against COVID-19
NMPA/Xinhua
December 14, 2021
Over 1.16 billion Chinese people have been fully vaccinated against COVID-19, a spokesperson for the National Health Commission said at a press conference on Dec 11.
-
Singapore HSA approves Pfizer-BioNTech’s shot for children
Pharmaceutical-Technology
December 14, 2021
Singapore’s Health Sciences Authority (HSA) has approved the usage of Pfizer-BioNTech’s Covid-19 vaccine, Comirnaty, for the paediatric population of ages five to 11 years.
-
NewsPoints Billionaire’s Bet on Pfizer Vaccine for China Fails to Pay Off
FirstWordPharma
December 13, 2021
Beijing is supporting a home-grown mRNA vaccine, allowing China's Walvax Biotechnology Co. to test its own experimental vaccine as a booster, Bloomberg reported.
-
FDA expands EUA to Covid-19 booster shot of Pfizer-BioNTech
Pharmaceutical-Technology
December 13, 2021
The US Food and Drug Administration (FDA) has granted expanded emergency use authorization (EUA) to Pfizer and BioNTech’s Covid-19 booster vaccine for people aged 16 years and above.
-
FDA Approves Pfizer Boosters for Teens Aged 16 to 17
Drugs
December 10, 2021
The U.S. Food and Drug Administration on Thursday approved the emergency use of the Pfizer COVID-19 booster shots for Americans aged 16 and 17 years old.
-
COVID Booster Cuts Death Rate by 90%, Israeli Study Finds
Drugs
December 09, 2021
Booster doses of Pfizer's coronavirus vaccine set recipients up to effectively withstand the ravages of both the Delta and Omicron variants, a group of new studies suggest.
-
UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response
PharmaTimes
December 08, 2021
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.
-
Hilleman Labs establishes Singapore's first pilot manufacturing facility for vaccine development
CPhIonline
December 08, 2021
A 30,000-sq. ft cGMP facility and a separate R&D site will work alongside each other to provide end-to end product development solutions for Singapore and low- and middle-income countries
-
Vaccine makers could make Omicron-specific booster, says Fauci
expresspharma
December 07, 2021
The US government is working with Moderna, Pfizer and J&J on multiple contingency plans, infectious disease expert Anthony Fauci told reporters at a White House briefing.
-
COVID-19 Vaccine, Testing Demand Overwhelming Pharmacies
Drugs
December 07, 2021
U.S. pharmacies are struggling to keep up with Americans' demand for COVID-19 vaccines and tests, and the pressure could intensify as antiviral pills to treat COVID-19 are approved by federal regulators.